{"id":"active-comparator-control-2","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3942279","moleculeType":"Small molecule","molecularWeight":"467.47"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It is used to compare the efficacy and safety of new treatments by serving as a standard against which the new treatments are measured.","oneSentence":"Active Comparator Control 2 is a drug that acts as a control in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:59:07.038Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 clinical trials"}]},"trialDetails":[{"nctId":"NCT07433556","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers","status":"RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2026-03-23","conditions":"Healhty","enrollment":86},{"nctId":"NCT07497113","phase":"NA","title":"The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguing Exercise in 18-45-year-old Male and Female Participants.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-03-01","conditions":"Healthy Participants","enrollment":62},{"nctId":"NCT07309393","phase":"NA","title":"Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function","status":"RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-12-31","conditions":"Residual Neuromuscular Block","enrollment":240},{"nctId":"NCT06279377","phase":"NA","title":"Examining the Effectiveness of Exercise Training After Cervical Laminoplasty Surgery","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2023-05-05","conditions":"Cervical Spine Disease, Surgery, Rehabilitation","enrollment":32},{"nctId":"NCT07046494","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder","status":"RECRUITING","sponsor":"Rapport Therapeutics Inc.","startDate":"2025-07-25","conditions":"Bipolar 1 Disorder","enrollment":224},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07494916","phase":"NA","title":"Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-02-02","conditions":"Sarcopenia, Aging, Physical Functional Performance","enrollment":30},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT06136793","phase":"NA","title":"HomeStyles-Adults of Chinese Heritage","status":"ENROLLING_BY_INVITATION","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-08-25","conditions":"Healthy Lifestyle, Home Environment Related Disease, Cardiometabolic Disease","enrollment":400},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT07228585","phase":"NA","title":"Comparison of the Effects of Kinesio Taping and Interval Exercise in Patients Diagnosed With Venous Insufficiency: A Randomised Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Necmettin Erbakan University","startDate":"2025-09-22","conditions":"Chronic Venous Insufficiency C2 and Below","enrollment":33},{"nctId":"NCT04499248","phase":"PHASE1, PHASE2","title":"AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension","status":"RECRUITING","sponsor":"AbbVie","startDate":"2020-11-16","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":96},{"nctId":"NCT06793397","phase":"PHASE3","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2025-12-10","conditions":"Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder","enrollment":330},{"nctId":"NCT07245368","phase":"PHASE1, PHASE2","title":"Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma","status":"RECRUITING","sponsor":"Prana Therapies Inc","startDate":"2025-11-04","conditions":"Mild to Moderate Asthma","enrollment":96},{"nctId":"NCT07300267","phase":"PHASE1","title":"A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-13","conditions":"Pneumococcal Infection","enrollment":210},{"nctId":"NCT07482176","phase":"PHASE3","title":"Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)","status":"RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2026-03-16","conditions":"Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD","enrollment":284},{"nctId":"NCT07481734","phase":"PHASE2","title":"Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis","enrollment":120},{"nctId":"NCT07481604","phase":"PHASE2","title":"Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above","status":"NOT_YET_RECRUITING","sponsor":"CHA Vaccine Institute Co., Ltd.","startDate":"2026-04","conditions":"Herpes Zoster","enrollment":135},{"nctId":"NCT01051895","phase":"NA","title":"Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2010-01","conditions":"High Grade Cervical Intra-epithelial Neoplasia","enrollment":2253},{"nctId":"NCT06151574","phase":"PHASE3","title":"Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2024-02-09","conditions":"Lung Cancer, Non-squamous, Non-small Cell","enrollment":416},{"nctId":"NCT05727189","phase":"PHASE1","title":"A Study of Idazoxan in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terran Biosciences Australia Pty Ltd","startDate":"2023-02-14","conditions":"Healthy","enrollment":150},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07310030","phase":"NA","title":"Neuro-Athletic Training Effects in Young Adults","status":"COMPLETED","sponsor":"Istinye University","startDate":"2026-01-01","conditions":"Health Young Individuals, Physical Fitness","enrollment":22},{"nctId":"NCT04404283","phase":"PHASE3","title":"Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seagen, a wholly owned subsidiary of Pfizer","startDate":"2020-08-20","conditions":"Diffuse Large B-cell Lymphoma","enrollment":238},{"nctId":"NCT07473752","phase":"PHASE1","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2023-07-18","conditions":"Phase 1 First-in-human Study Involving Healthy Subjects","enrollment":26},{"nctId":"NCT07472374","phase":"PHASE3","title":"Functional Restoration for Chronic Low Back Pain: Medico-economic Impact","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-10","conditions":"Nonspecific Chronic Low Back Pain With Work Disability","enrollment":242},{"nctId":"NCT07473544","phase":"NA","title":"Essential Oil Inhalation and Acute Stress Response in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-03-10","conditions":"Psychological Stress","enrollment":200},{"nctId":"NCT07105007","phase":"NA","title":"Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-08-15","conditions":"HIV, Heart Failure","enrollment":30},{"nctId":"NCT06878404","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-21","conditions":"Arthritis, Psoriatic","enrollment":552},{"nctId":"NCT07469046","phase":"PHASE3","title":"VAH vs VA in Newly Diagnosed Elderly AML","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-03-01","conditions":"Acute Myeloid Leukemia (AML), Elderly Patients (60-75 Years)","enrollment":308},{"nctId":"NCT06934226","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-04-15","conditions":"Plaque Psoriasis","enrollment":752},{"nctId":"NCT07291635","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine","status":"RECRUITING","sponsor":"Aramis Biotechnologies Inc.","startDate":"2026-02-25","conditions":"Influenza","enrollment":728},{"nctId":"NCT06608277","phase":"PHASE2","title":"Ketamine, SGB and Combination Treatment for TBI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-02","conditions":"Posttraumatic Headache, Posttraumatic Stress Disorder","enrollment":175},{"nctId":"NCT03451851","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-07-11","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT07112872","phase":"PHASE2","title":"A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-08-19","conditions":"Type 2 Diabetes Mellitus","enrollment":240},{"nctId":"NCT06220604","phase":"PHASE3","title":"A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-03-09","conditions":"Plaque Psoriasis","enrollment":731},{"nctId":"NCT06641089","phase":"PHASE3","title":"Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response","status":"RECRUITING","sponsor":"MoonLake Immunotherapeutics AG","startDate":"2024-10-15","conditions":"Arthritis, Psoriatic","enrollment":600},{"nctId":"NCT06132581","phase":"NA","title":"Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression","status":"RECRUITING","sponsor":"Florida State University","startDate":"2024-01-24","conditions":"Major Depressive Disorder, Anhedonia","enrollment":72},{"nctId":"NCT07214974","phase":"EARLY_PHASE1","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","status":"NOT_YET_RECRUITING","sponsor":"Noah Tech, Corp.","startDate":"2026-09-01","conditions":"Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline, Alzheimer's Disease Dementia","enrollment":600},{"nctId":"NCT07117357","phase":"NA","title":"Neuroathletic Training Effects on Muscle Strength, Balance, and Cognition","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2025-04-11","conditions":"Neuroathletic Training, Posterior Chain Muscle Strength, Gluteus Maximus","enrollment":52},{"nctId":"NCT06973109","phase":"PHASE2","title":"Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nitin Agarwal","startDate":"2026-03-20","conditions":"Osteoporosis, Post-menopausal","enrollment":36},{"nctId":"NCT06961006","phase":"PHASE2","title":"A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-29","conditions":"Malignant Melanoma","enrollment":160},{"nctId":"NCT07444996","phase":"NA","title":"Effect of Magnetotherapy Combined With Cold Application and Exercise in Patients With Lateral Epicondylitis","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-27","conditions":"Magnetotherapy, Lateral Epicondylitis (Tennis Elbow)","enrollment":40},{"nctId":"NCT06961370","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-07-16","conditions":"Geographic Atrophy, Age-related Macular Degeneration","enrollment":132},{"nctId":"NCT06619990","phase":"PHASE1, PHASE2","title":"Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis","status":"RECRUITING","sponsor":"Xencor, Inc.","startDate":"2024-10-10","conditions":"Ulcerative Colitis (UC)","enrollment":270},{"nctId":"NCT06196840","phase":"PHASE2","title":"Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Innostellar Biotherapeutics Co.,Ltd","startDate":"2024-01-24","conditions":"Neovascular Age-Related Macular Degeneration","enrollment":50},{"nctId":"NCT06166056","phase":"PHASE1, PHASE2","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-11-29","conditions":"Bronchiectasis","enrollment":45},{"nctId":"NCT06475495","phase":"PHASE1, PHASE2","title":"Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2024-12-04","conditions":"Rheumatoid Arthritis","enrollment":13},{"nctId":"NCT06762392","phase":"NA","title":"Effectiveness of Blood Flow Restriction in Postoperative Rehabilitation for Anterior Cruciate Ligament Injuries. A Pilot Study.","status":"RECRUITING","sponsor":"University of Valencia","startDate":"2025-01-01","conditions":"Anterior Cruciate Ligament Reconstruction Rehabilitation","enrollment":40},{"nctId":"NCT03319498","phase":"NA","title":"Postpartum Urinary Retention With Essential Oils (PURE)","status":"TERMINATED","sponsor":"Mount Carmel Health System","startDate":"2018-01-01","conditions":"Urinary Retention","enrollment":77},{"nctId":"NCT03982381","phase":"PHASE4","title":"SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2019-09-05","conditions":"Type 2 Diabetes","enrollment":2067},{"nctId":"NCT07450547","phase":"PHASE2","title":"Phase 2 Study to Assess the Safety and Efficacy of ANG003","status":"NOT_YET_RECRUITING","sponsor":"Anagram Therapeutics, Inc.","startDate":"2026-04","conditions":"Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)","enrollment":113},{"nctId":"NCT07448506","phase":"PHASE3","title":"PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.","status":"COMPLETED","sponsor":"Laboratorios Richmond S.A.C.I.F.","startDate":"2024-07-09","conditions":"High Blood Pressure (& [Essential Hypertension])","enrollment":50},{"nctId":"NCT06937931","phase":"PHASE2","title":"A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults","status":"RECRUITING","sponsor":"Ipsen","startDate":"2025-06-30","conditions":"Cervical Dystonia","enrollment":132},{"nctId":"NCT06875947","phase":"NA","title":"EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Padjadjaran","startDate":"2025-05-23","conditions":"Iron Deficiency Anemia of Pregnancy, Pregnancy Complications, Inflammation","enrollment":59},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT05696080","phase":"PHASE3","title":"Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-13","conditions":"Pneumococcal Infection","enrollment":518},{"nctId":"NCT05569954","phase":"PHASE3","title":"Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-11-07","conditions":"Pneumococcal Disease","enrollment":1484},{"nctId":"NCT07436325","phase":"NA","title":"Gingival Health After Zirconia Versus Stainless Steel Crowns in Children","status":"NOT_YET_RECRUITING","sponsor":"Murad Alrashidi","startDate":"2026-03","conditions":"Gingival Disease","enrollment":100},{"nctId":"NCT07437001","phase":"NA","title":"Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal Women","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-01","conditions":"Postmenopausal Women","enrollment":60},{"nctId":"NCT07436286","phase":"NA","title":"Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour","status":"COMPLETED","sponsor":"Dangana Zakari Adeka","startDate":"2018-02-01","conditions":"Postpartum Hemorrhage (PPH), Postpartum Hemorrhage Third Stage of Labour Retained Placenta","enrollment":416},{"nctId":"NCT07440706","phase":"NA","title":"Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-10-15","conditions":"Dumping Syndrome, Post-bariatric Hypoglycemia","enrollment":60},{"nctId":"NCT06931639","phase":"NA","title":"Suicide Preventive Psychosocial Treatment for Youths","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-05-28","conditions":"Suicide Attempt, Suicidal and Self-injurious Behavior, Suicide Attempted","enrollment":282},{"nctId":"NCT07432139","phase":"NA","title":"Brief Emotion-Focused Therapy for Self-Criticism: A Comparison With a Cognitive-Behavioral Therapy Approach","status":"COMPLETED","sponsor":"Catarina Teixeira","startDate":"2025-04-17","conditions":"Emotion Focused Therapy, Cognitive Behavioral Therapy","enrollment":95},{"nctId":"NCT07434453","phase":"NA","title":"\"Topical Tranexamic Acid With Flap Fixation: A Novel Approach to Minimize Post-operative Drainage and Surgical Site Infection in Patients Undergoing Modified Radical Mastectomy\"","status":"COMPLETED","sponsor":"Noor ul Ain","startDate":"2023-08-04","conditions":"Breast Cancer Females","enrollment":62},{"nctId":"NCT07266805","phase":"PHASE3","title":"Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency","status":"RECRUITING","sponsor":"Pharvaris Netherlands B.V.","startDate":"2025-10-16","conditions":"Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)","enrollment":32},{"nctId":"NCT07431476","phase":"PHASE4","title":"Brimonidine 0.33% for Rosacea-Related Facial Erythema","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2025-05-01","conditions":"Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)","enrollment":45},{"nctId":"NCT06868290","phase":"PHASE2","title":"Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-03-13","conditions":"ANCA Associated Vasculitis (AAV)","enrollment":126},{"nctId":"NCT07425093","phase":"NA","title":"Investigation of the Relationship Between Gray and White Matter Volumes, Walking Exercise, and Body Fat Percentage in Adults With a Body Mass Index Above 25","status":"COMPLETED","sponsor":"Amasya University","startDate":"2024-01-01","conditions":"Obesity & Overweight, Headache, Sedentary Lifestyle","enrollment":22},{"nctId":"NCT07069140","phase":"NA","title":"Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy","status":"RECRUITING","sponsor":"University of Pavia","startDate":"2025-07-30","conditions":"Pregnancy, Periodontal Disease, Gingivitis","enrollment":40},{"nctId":"NCT07422272","phase":"NA","title":"Acute Effects of LLLT on Pain Threshold and Pain Tolerance","status":"RECRUITING","sponsor":"European University of Lefke","startDate":"2025-12-15","conditions":"Pain Threshold, Pain Tolerance, Acute Pain","enrollment":52},{"nctId":"NCT05294991","phase":"NA","title":"Wellness App for Sleep Disturbance in Hematological Cancer Patients","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2023-02-20","conditions":"Cancer, Sleep Disturbance, Anxiety","enrollment":276},{"nctId":"NCT07419672","phase":"NA","title":"Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste","status":"COMPLETED","sponsor":"Church & Dwight Company, Inc.","startDate":"2024-08-12","conditions":"Dental Caries","enrollment":31},{"nctId":"NCT06954428","phase":"PHASE1","title":"Clinical Trial of Intranasal Delivery of NT-301","status":"COMPLETED","sponsor":"Nano PharmaSolutions Australia","startDate":"2025-06-20","conditions":"Tolerability of NT-301 Nasal Spray, Pharmacokinetics of NT-301 Nasal Spray, Safety of NT-301 Nasal Spray","enrollment":49},{"nctId":"NCT06581406","phase":"PHASE2, PHASE3","title":"A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma","status":"RECRUITING","sponsor":"Replimune Inc.","startDate":"2024-12-17","conditions":"Metastatic Uveal Melanoma","enrollment":280},{"nctId":"NCT07417306","phase":"PHASE3","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2026-03-27","conditions":"Type 2 Diabetes","enrollment":912},{"nctId":"NCT07412223","phase":"PHASE4","title":"Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2026-02-24","conditions":"Pain, Postoperative, Postoperative Ileus","enrollment":152},{"nctId":"NCT07413887","phase":"NA","title":"The STIME Project: Intersectoral Prevention of Severe Youth Mental Health Difficulties","status":"RECRUITING","sponsor":"Center for Clinical Research and Prevention","startDate":"2025-11-20","conditions":"Preventive Intervention, Mental Health Difficulties","enrollment":1200},{"nctId":"NCT07260500","phase":"PHASE2","title":"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-11-11","conditions":"Short Stature Children Born Small for Gestational Age (SGA)","enrollment":72},{"nctId":"NCT05005845","phase":"PHASE2","title":"NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)","status":"COMPLETED","sponsor":"NFlection Therapeutics, Inc.","startDate":"2021-09-29","conditions":"Cutaneous Neurofibroma, Neurofibromatosis 1","enrollment":199},{"nctId":"NCT07104383","phase":"PHASE3","title":"VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)","status":"RECRUITING","sponsor":"Viking Therapeutics, Inc.","startDate":"2025-06-23","conditions":"Weight Loss","enrollment":1100},{"nctId":"NCT05197270","phase":"PHASE1, PHASE2","title":"4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration","status":"RECRUITING","sponsor":"4D Molecular Therapeutics","startDate":"2021-12-09","conditions":"Neovascular (Wet) Age-Related Macular Degeneration","enrollment":215},{"nctId":"NCT07280858","phase":"PHASE1, PHASE2","title":"A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.","status":"RECRUITING","sponsor":"SK Bioscience Co., Ltd.","startDate":"2026-01-28","conditions":"Healthy Participants, Sarbecovirus","enrollment":368},{"nctId":"NCT07055217","phase":"NA","title":"Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-11-04","conditions":"Repetitive Negative Thinking, Neurofeedback","enrollment":100},{"nctId":"NCT05179759","phase":"NA","title":"Teachers Leading the Frontlines (Tealeaf) - a Hybrid Effectiveness, Implement, and Context Trial","status":"ENROLLING_BY_INVITATION","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-02-20","conditions":"Child Behavior Disorders","enrollment":20160},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT05698498","phase":"NA","title":"Silicon Valley Guaranteed Income Project","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Francisco","startDate":"2022-12-10","conditions":"Families Experiencing Homelessness and/or Housing Instability, Housing Stability","enrollment":300},{"nctId":"NCT07400003","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine","status":"RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2026-01-06","conditions":"Herpes Zoster, mRNA Vaccine","enrollment":519},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT06442462","phase":"PHASE2","title":"Study of SPG302 in Adults With Schizophrenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Spinogenix","startDate":"2024-08-01","conditions":"Schizophrenia","enrollment":32},{"nctId":"NCT07393334","phase":"PHASE2","title":"Effects of NLS-133, a Potential Non-Hormonal \"On-Demand\" Male Contraceptive","status":"RECRUITING","sponsor":"Next Life Sciences","startDate":"2025-12-02","conditions":"Male Contraception, Semen Volume, Sperm Motility","enrollment":10},{"nctId":"NCT07321327","phase":"NA","title":"Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2","status":"ENROLLING_BY_INVITATION","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-02-03","conditions":"Attention Deficit Hyperactivity Disorder Symptoms","enrollment":100},{"nctId":"NCT06665256","phase":"PHASE2","title":"Phase 2 Study of Rapcabtagene Autoleucel in Myositis","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-12-17","conditions":"Idiopathic Inflammatory Myopathies","enrollment":123},{"nctId":"NCT07389265","phase":"PHASE3","title":"Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2025-10-01","conditions":"Metastatic Colorectal Cancer (mCRC)","enrollment":480},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":"Suspected Invasive Mould Infection","enrollment":80},{"nctId":"NCT07064564","phase":"PHASE1","title":"iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Akyso Therapeutics, LLC","startDate":"2026-04-01","conditions":"Opioid Use Disorder","enrollment":33},{"nctId":"NCT05393037","phase":"PHASE3","title":"Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-07-13","conditions":"Pneumococcal Disease","enrollment":313},{"nctId":"NCT07385989","phase":"PHASE2","title":"Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"WEI XU","startDate":"2026-01-25","conditions":"Extranodal NK/T-cell Lymphoma","enrollment":40},{"nctId":"NCT07382427","phase":"PHASE2","title":"A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails","status":"NOT_YET_RECRUITING","sponsor":"Onyx Axiom","startDate":"2026-03","conditions":"Onychomycosis of Toenail","enrollment":200},{"nctId":"NCT06735794","phase":"NA","title":"Impact of Spaced iTBS on Plasticity in the Motor Cortex","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-11-13","conditions":"Healthy Control Subjects","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1165,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["HLIM Placebo+SA160021 Placebo+SA160022"],"phase":"phase_3","status":"active","brandName":"Active Comparator Control 2","genericName":"Active Comparator Control 2","companyName":"SamA Pharmaceutical Co., Ltd","companyId":"sama-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Active Comparator Control 2 is a drug that acts as a control in clinical trials. Used for Phase 3 clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}